Literature DB >> 24751000

Gene expression profile of 5-fluorouracil metabolic enzymes in laryngeal cancer cell line: predictive parameters for response to 5-fluorouracil-based chemotherapy.

Ana Lívia Silva Galbiatti1, Heloisa Cristina Caldas2, José Victor Maniglia3, Erika Cristina Pavarino4, Eny Maria Goloni-Bertollo4.   

Abstract

BACKGROUND: 5-fluorouracil (5-FU) is an antifolate chemotherapeutic that has become established in many therapeutic regimes, but sensitivity variations and development of resistance are common problems that limit the efficiency of the treatments. Inter-individual variations to 5-FU outcome have been attributed to different expression profiles of genes related to folate metabolism.
METHODS: To elucidate the mechanisms of variations to 5-FU outcome, the authors investigated MTHFR, DHFR, TYMS and SLC19A1 folate genes expression for 5-FU response in laryngeal cancer cell line (Hep-2). Concentrations of 10, 50, and 100 ng/mL of 5-FU chemotherapeutic were added separately in Hep-2 cell line for 24 hours at 37 °C. Cell sensibility was evaluated with fluorescein isothiocyanate (FITC) label Bcl-2 by flow cytometry. The real-time quantitative PCR (qPCR) technique was performed for quantification of gene expression using TaqMan(®) Gene Expression Assay. ANOVA and Bonferroni's post hoc tests were utilized to statistical analysis.
RESULTS: The numbers of viable Hep-2 cells with 10, 50, and 100 ng/mL concentrations of 5-FU chemotherapy were 15.87, 28.3 and 68.9%, respectively. Statistical analysis showed significant association between control group and increased expression for TYMS gene in cells treated with 100 ng/mL/5-FU chemotherapy (P<0.05).
CONCLUSIONS: The authors found association between the highest 5-FU dose chemotherapy and increased expression levels for TYMS folate gene in laryngeal cancer cell line. Although these experiments were performed in vitro, the results suggest that genetic factors are thought to play an important role in drug metabolism and may be useful for predicting treatment outcomes.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fluorouracil; Gene expression; Laryngeal neoplasms

Mesh:

Substances:

Year:  2014        PMID: 24751000     DOI: 10.1016/j.biopha.2014.03.015

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.

Authors:  Fei Xu; Ming-Liang Ye; Yu-Peng Zhang; Wen-Jie Li; Meng-Ting Li; Hai-Zhou Wang; Xiao Qiu; Yan Xu; Jin-Wen Yin; Qian Hu; Wan-Hui Wei; Ying Chang; Lan Liu; Qiu Zhao
Journal:  Cancer Sci       Date:  2020-03-14       Impact factor: 6.716

2.  Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.

Authors:  Isolde Summerer; Julia Hess; Adriana Pitea; Kristian Unger; Ludwig Hieber; Martin Selmansberger; Kirsten Lauber; Horst Zitzelsberger
Journal:  BMC Genomics       Date:  2015-09-02       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.